Cyclooxygenase‐2 inhibition causes antiangiogenic effects on tumor endothelial and vascular progenitor cells
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Tumor angiogenesis is necessary for solid tumor progression and metastasis. Cyclooxygenase (COX)‐2 is known to play an important role in cancer growth and invasion, and it activates the signaling pathways controlling cell proliferation, migration, apoptosis, and angiogenesis. COX‐2 is reported to be expressed in many cancer cells. Several studies have reported successful treatment of cancer cells with COX‐2 inhibitors (COX‐2is). However, the effect of COX‐2 inhibition on the tumor endothelium remains to be elucidated. Our study shows that COX‐2 is expressed in the vasculature of surgically resected human tumors. To investigate the effects of COX‐2 inhibition on the tumor endothelium in vitro, we isolated tumor endothelial cells (TECs) from human melanoma and oral carcinoma xenografts in mice, in which we confirmed that tumor growth was suppressed by inhibiting angiogenesis with the COX‐2is NS398. COX‐2 mRNA was upregulated in TECs compared to normal endothelial cells (NECs). Cell migration and proliferation were suppressed by NS398 in TECs but not in NECs. The effects of NS398 in vivo were consistent with the in vitro results. The number of CD133+/vascular endothelial growth factor receptor‐2+ cells in circulation was significantly suppressed by COX‐2 inhibition. In addition, the number of progenitor marker‐positive cells decreased in the tumor blood vessels after COX‐2i treatment, which suggests that the homing of progenitor cells into the tumor was also blocked. We conclude that NS398 specifically targets both TECs and vascular progenitor cells without affecting NECs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis as a therapeutic target
Ferrara, N., & Kerbel, R. S. (2005) · Nature · doi:10.1038/nature04483 · Cited by 2,653 · cited 1×
“In the tumor microenvironment, angiogenesis is necessary for tumor progression and metastasis.(2) Control of tumor angiogenesis is therefore a very important preventive strategy against invasive cancers.”
BackgroundRegulation of angiogenesis by hypoxia: role of the HIF system
Pugh, C. W., & Ratcliffe, P. J. (2003) · Nature Medicine · doi:10.1038/nm0603-677 · Cited by 2,520
Cyclooxygenase regulates angiogenesis induced by colon cancer cells
Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., & DuBois, R. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81433-6 · Cited by 2,272
Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1194 · Cited by 1,860 · cited 1×
“It was recently indicated that tumors mobilize bone marrow (BM)-derived EPCs in addition to recruiting neighboring blood vessels or ECs and that EPCs migrate to tumors and become incorporated into their developing vasculature.(32)”
BackgroundKaidi, A., Qualtrough, D., Williams, A. C., & Paraskeva, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0425 · Cited by 300 · cited 1×
“COX-2 is a key enzyme in prostaglandin production and is also known to be upregulated during inflammation and in tumor tissues.(4) Nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit COX-2 activity, and chronic intake of NSAIDs is known to significantly reduce the risk of colon cancer development.”
Background
Cited by
Contribution of Tumor Endothelial Cells in Cancer Progression
Hida, K., Maishi, N., Annan, D., & Hida, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051272 · Cited by 259
Self-citationEndothelial Cells in the Tumor Microenvironment
Sobierajska, K., Ciszewski, W. M., Sacewicz-Hofman, I., & Niewiarowska, J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-37184-5_6 · Cited by 179
Nanoparticle Interactions with the Tumor Microenvironment
Huai, Y., Hossen, M. N., Wilhelm, S., Bhattacharya, R., & Mukherjee, P. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00448 · Cited by 113
Tumor endothelial cells with high aldehyde dehydrogenase activity show drug resistance
Hida, K., Maishi, N., Akiyama, K., Ohmura‐Kakutani, H., Torii, C., Ohga, N., Osawa, T., Kikuchi, H., Morimoto, H., Morimoto, M., et al. (2017) · Cancer Science · doi:10.1111/cas.13388 · Cited by 48
Self-citation
Metadata
- Authors
- Muraki, C., Ohga, N., Hida, Y., Nishihara, H., Kato, Y., Tsuchiya, K., Matsuda, K., Totsuka, Y., Shindoh, M., & Hida, K.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2011-04-20
- Volume
- 130
- Issue
- 1
- Pages
- 59-70
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1970062829
- Cited by
- 57
- References
- 5
- FWCI
- 2.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cyclooxygenase‐2 inhibition causes antiangiogenic effects on tumor endothelial and vascular progenitor cells. https://app.cochat.ai/papers/10.1002/ijc.25976
- The paper
- Muraki, C., Ohga, N., Hida, Y., Nishihara, H., Kato, Y., Tsuchiya, K., Matsuda, K., Totsuka, Y., Shindoh, M., & Hida, K. (2012). Cyclooxygenase‐2 inhibition causes antiangiogenic effects on tumor endothelial and vascular progenitor cells. International Journal of Cancer. https://doi.org/10.1002/ijc.25976
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.